Early bird registration is open and closes May 2025. Register now

  • 00Days
  • 00Hrs
  • 00Mins
  • 00Secs

Francesca Lim

Affiliation/region: Singapore General Hospital, Southeast Asia
Francesca Lim - Singapore General Hospital

Dr Francesca Lim is a senior consultant with the department of Haematology at the Singapore General Hospital where she leads the clinical immune effector cell therapy programme. She is also the Head of SingHealth Duke NUS Cell Therapy Center which helps to coordinate both clinical and research efforts across the Institutions at SingHealth. She is the first chief medical officer for the advanced cell therapy research institute Singapore, the National GMP facility and was instrumental in leading the team towards GMP certification and manufacturing licence.

Share

Key dates

Registrations
Abstracts

More speakers

Shigeki Momohara - Hakkeikai Incorporated Medical Institution / Kusanagi Orthopedic & Rheumatologic Clinic

Shigeki Momohara

Hakkeikai Incorporated Medical Institution / Kusanagi Orthopedic & Rheumatologic Clinic, East Asia
Yuichi Mochida - Yokohama City University

Yuichi Mochida

Yokohama City University, East Asia
Roger A Levy - Global Medical Affairs

Roger A Levy

Global Medical Affairs, GlaxoSmithKline, America
Maureen Rischmueller - The Queen Elizabeth Hospital

Maureen Rischmueller

The Queen Elizabeth Hospital, Oceania
Chengappa Kavadichanda - RheumaCARE

Chengappa Kavadichanda

RheumaCARE, South Asia
Masatoshi Kanda - Division of Rheumatology and Clinical Immunology Department of Internal Medicine Sapporo Medical University

Masatoshi Kanda

Division of Rheumatology and Clinical Immunology Department of Internal Medicine Sapporo Medical University, East Asia